Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study

Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study

Abstract Introduction The 2010 release of an abuse deterrent formulation (ADF) of OxyContin, a brand name prescription opioid, has been cited as a major driver for the reduction in prescription drug misuse and the associated increasing illicit opioid use and overdose rates. However, studies of this...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Eric W. Lundstrom, Zheng Dai, Caroline P. Groth, Brian Hendricks, Erin L. Winstanley, Marie Abate, Gordon S. Smith
Formatua: Artikulua
Hizkuntza:English
Argitaratua: BMC 2024-01-01
Saila:Substance Abuse Treatment, Prevention, and Policy
Gaiak:
Opioids
Overdose
Abuse deterrent formulation
Interrupted Time Series Analysis
West Virginia
Sarrera elektronikoa:https://doi.org/10.1186/s13011-023-00587-2

Internet

https://doi.org/10.1186/s13011-023-00587-2

Antzeko izenburuak